By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway
Suite B
Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


Company News
Provectus Announces Pricing Of Public Offering To Raise $6 Million 8/25/2016 10:22:19 AM
Provectus Announces Proposed Public Offering Of Preferred Stock And Warrants 8/25/2016 10:20:26 AM
Provectus Receives Patent From USPTO Related To Rose Bengal Analogs 8/23/2016 9:42:52 AM
ProvectusReports Second Quarter 2016 Financial Results 8/10/2016 11:16:30 AM
Provectus Announces Poster Presentation On PV-10 For Melanoma At European Society For Medical Oncology 2016 Congress 8/1/2016 11:05:20 AM
Provectus Will Hold Its 2016 Second Quarter Business Update Conference Call On Wednesday, August 10, 2016, At 4 PM Eastern Daylight Time 7/20/2016 8:47:43 AM
Provectus Receives Patent Allowance For Use Of Halogenated Xanthenes In Pharmaceutical Compositions And As Medicaments 7/18/2016 9:54:30 AM
Provectus Establishes Australian Subsidiary 7/14/2016 10:18:28 AM
Provectus Announces PV-10 Data Discussed At 6th European Post-Chicago Melanoma/Skin Cancer Meeting 7/13/2016 10:53:18 AM
Provectus Announces Acceptance Of Abstract For Poster Presentation At European Society For Medical Oncology 2016 Congress 7/12/2016 10:31:14 AM